Shopify’s (SHOP) Stock Price Soars As Short Seller Throws in the Towel

Citron Research admits defeat and moves away from shorting stocks such as Shopify (TSX:SHOP)(NYSE:SHOP).

| More on:

Since going public, Shopify (TSX:SHOP)(NYSE:SHOP) has been one of Canada’s most prolific stocks. Shareholders who were lucky enough to get in on the company at its IPO price would be sitting on gains in excess of 1,450%! One of the downsides of being an industry disruptor and one of the top performers as that there will always be skeptics.

In the markets, these skeptics take many forms, but one of the most polarizing is the short seller, which is a bearish investors who makes significant bets against the company. In extreme cases, a short seller will spend considerable time and effort trying to market their bearish outlook to the masses.

In Shopify’s case, it was attacked repeatedly by notable short seller Andrew Left, Managing Partner at Citron Research. Citron is known for making big marketing splashes.

It wows retail investors with fancy graphics, videos and pages of pages worth of information. The problem with this approach is that it is akin to fear mongering.

When it first began to short SHOP, Andrew Left released a video detailing how the Federal Trade Commission (FTC) would take notice of the unique software as a service (SaaS) business model.

The video had its intended success: SHOP dipped by double digits in the days following, yet nothing from the FTC ever materialized.

As the markets warmed up to the SaaS leader again, it blazed to new highs. Over the years, Citron predictably put out new short reports on the company as it rode momentum to outsized gains. The good news, is that the markets quickly adapted to Citron’s game and the last “Hail Mary” fell flat.

Citron Research’s most recent short report came last April when it made a bold claim: Shopify would crater to US$100 per share. At the time, the company was trading at $198 per share.

In effect, Left and his team expected this tech giant to lose 50% of its value. Along with the report, it also lobbed the following: if SHOP was trading at more than $200 per share within a year, it would donate $200,000 to the Robin Hood Foundation.

The last report reeked of desperation and was a classic example of fear mongering. In turn, the markets largely ignored the report. What happened next?

The software leader went about its business hitting new 52-week highs almost daily. As of writing, the company is trading at US$414.00, more than double the amount seen when the last short report surfaced.

It is therefore not surprising, that earlier this week Citron Research effectively threw in the towel on the SaaS company. It is welcomed news for shareholders. In Andrew Left’s Annual Investment Letter, he had this to say:

“While we were fortunate not to be short Tesla in its recent surge to over $420, we had a small position in Shopify turn into a large loser as we ignored the bigger story of what we believed was an overpriced SaaS company with competition looming. Either way, going forward this type of story is too large for us to get our little hands around.”

Admitting defeat is not easy, and Citron should be commended for recognizing the error of their ways. Just as Andrew Left learnt from his experience, so too should retail investors.

There are times when short sellers’ thesis will be correct, and others when it won’t. The key lesson for investors is not to get swayed by fancy reports, and oodles of information. The one who screams loudest isn’t necessarily the one that is right.

It is critical for investors to do their own due diligence. Over the years, I have recommended that investors ignore the short sellers. All signs pointed to Shopify as a healthy, and financially stable industry leader that was exceeding expectations. It remains as such.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor mlitalien owns shares of Shopify. Tom Gardner owns shares of Shopify. The Motley Fool owns shares of and recommends Shopify and Shopify. Shopify is a recommendation of Stock Advisor Canada.

More on Tech Stocks

Canada Day fireworks over two Adirondack chairs on the wooden dock in Ontario, Canada
Tech Stocks

Best Tech Stocks for Canadian Investors in the New Year

Three tech stocks are the best options for Canadians investing in the high-growth sector.

Read more »

doctor uses telehealth
Tech Stocks

What to Know About Canadian Small-Cap Stocks for 2025

Small cap stocks are a great way to experience outsized gains. Here is what you need to know about small…

Read more »

A worker drinks out of a mug in an office.
Tech Stocks

A Top-Performing U.S. Stock That Canadian Investors Really Should Own

Canadian investors should buy and hold this top performing U.S. stock for generating significant returns in the long run.

Read more »

dividends grow over time
Tech Stocks

Got $1,500? 2 Tech Stocks to Buy and Hold Forever

Two tech stocks with high-growth potential are sound prospects for long-term investors.

Read more »

Soundhound AI is a leader in voice recognition software
Tech Stocks

3 Tech Stocks I’m Looking to Buy in January

From tech stocks with consistent growth histories to stocks experiencing a temporary bullish momentum, there are multiple attractive options in…

Read more »

The TFSA is a powerful savings vehicle for Canadians who are saving for retirement.
Tech Stocks

Take Full Advantage of Your TFSA: Growth Strategies for 2025

Maximize your TFSA in 2025 with proven growth strategies. Learn how to build a tax-free portfolio, avoid common mistakes, and…

Read more »

up arrow on wooden blocks
Tech Stocks

1 Soaring Stock I’d Buy Now With No Hesitation

Although it's from a rapidly evolving discipline and carries unique risks, the robotics stock's growth potential is too formidable and…

Read more »

Biotech stocks
Tech Stocks

Digital Healthcare Boom: 2 TSX Stocks Transforming Canadian Medicine

Even though telehealth stocks carry the risk factor of the tech sector and other innovative stocks, the profit margin can…

Read more »